Page last updated: 2024-09-04

carbapenems and Encapsulating Peritoneal Sclerosis

carbapenems has been researched along with Encapsulating Peritoneal Sclerosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Amico, G; Conaldi, PG; Douradinha, B; Gruttadauria, S; Iannolo, G; Mularoni, A; Pampalone, M; Pietrosi, G; Vitale, G	1

Other Studies

1 other study(ies) available for carbapenems and Encapsulating Peritoneal Sclerosis

Article	Year
Human Amnion-Derived Mesenchymal Stromal Cells: A New Potential Treatment for Carbapenem-Resistant International journal of molecular sciences, 2022, Jan-13, Volume: 23, Issue:2 Topics: Amnion; Bacterial Load; beta-Lactam Resistance; Biomarkers; Carbapenems; Complement Activation; Complement System Proteins; Disease Susceptibility; Enterobacter; Enterobacteriaceae Infections; Humans; Immunomodulation; Inflammation Mediators; Macrophages; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Peritoneal Fibrosis; Peritonitis; Phagocytosis; Receptors, Pattern Recognition; Treatment Outcome	2022

Article

Year

Human Amnion-Derived Mesenchymal Stromal Cells: A New Potential Treatment for Carbapenem-Resistant

International journal of molecular sciences, 2022, Jan-13, Volume: 23, Issue:2

Topics: Amnion; Bacterial Load; beta-Lactam Resistance; Biomarkers; Carbapenems; Complement Activation; Complement System Proteins; Disease Susceptibility; Enterobacter; Enterobacteriaceae Infections; Humans; Immunomodulation; Inflammation Mediators; Macrophages; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Peritoneal Fibrosis; Peritonitis; Phagocytosis; Receptors, Pattern Recognition; Treatment Outcome

2022